Confidential IPV Screening Tool

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

19655 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-10-06

Study Completion Date

2023-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Effectiveness of Computer Screening for Intimate Partner Violence

NCT00166062

Domestic Violence Perpetration

COMPLETED NA

Intimate Partner Violence (IPV)Screening in Health Care Clinics in Rural South Carolina

NCT00164567

Partner Abuse

COMPLETED PHASE2

Addressing Intimate Partner Violence Among Women Veterans

NCT04106193

Intimate Partner Violence

COMPLETED NA

Computer-assisted Screening for Intimate Partner Violence in Family Practice

NCT00385034

Screening for Partner Violence

COMPLETED NA

Evaluation of an Intimate Partner Violence Screening-Intervention

NCT00257296

Domestic Violence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study was to develop and evaluate an integrated suite of electronic health record (EHR) tools that automates "best practices" from Northern California Kaiser Permanente for screening and intervention for IPV identified within clinical settings. The goal of the intervention goes beyond mere screening of patients for IPV and includes tools for assessment of IPV risk, for documentation of IPV care, and support for a warm hand-off during the primary care visit to a national IPV hotline resource. Importantly, the study includes work to keep notes documenting IPV and billing for IPV care confidential, segmenting this care in a secure segment of the electronic health record.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Violence, Domestic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

This is a stepped wedge cluster randomized trial which has 3 sequences starting intervention in randomized order.

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sequence 1

5 clinics. In stepped wedge design study, this was the sequence with shortest control (run-in) period.

All sequences have a run-in period and intervention period. In control period participants were screened using existing nurse-led oral screening, in intervention period both - nurse-led and our new confidential screen were used at the same time.

Group Type OTHER

Screening for intimate partner violence

Intervention Type DIAGNOSTIC_TEST

confidential screening using exam computer

Assessment and referral

Intervention Type OTHER

confidential assessment and referral of high-risk patients using decision-support templates

Sequence 2

5 clinics.

Group Type OTHER

Screening for intimate partner violence

Intervention Type DIAGNOSTIC_TEST

confidential screening using exam computer

Assessment and referral

Intervention Type OTHER

confidential assessment and referral of high-risk patients using decision-support templates

Sequence 3

5 clinics. This was the sequence with longest control (run-in) period.

Group Type OTHER

Screening for intimate partner violence

Intervention Type DIAGNOSTIC_TEST

confidential screening using exam computer

Assessment and referral

Intervention Type OTHER

confidential assessment and referral of high-risk patients using decision-support templates

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Screening for intimate partner violence

confidential screening using exam computer

Intervention Type DIAGNOSTIC_TEST

Assessment and referral

confidential assessment and referral of high-risk patients using decision-support templates

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being an Medical University of South Carolina patient at primary care clinics (family medicine)
* Women 18-49 years of age inclusive
* Reported yes to wanting to be contacted for a follow-up research study
* English-speaking

Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No